Literature DB >> 26306640

Reinitiation of mRNA translation in a patient with X-linked infantile spasms with a protein-truncating variant in ARX.

Ching Moey1,2, Scott Topper3, Mary Karn4, Amy Knight Johnson3, Soma Das3, Jorge Vidaurre5, Cheryl Shoubridge1,2.   

Abstract

Mutations in the Aristaless-related homeobox gene (ARX) lead to a range of X-linked intellectual disability phenotypes, with truncating variants generally resulting in severe X-linked lissencephaly with ambiguous genitalia (XLAG), and polyalanine expansions and missense variants resulting in infantile spasms. We report two male patients with early-onset infantile spasms in whom a novel c.34G>T (p.(E12*)) variant was identified in the ARX gene. A similar variant c.81C>G (p.(Y27*)), has previously been described in two affected cousins with early-onset infantile spasms, leading to reinitiation of ARX mRNA translation resulting in an N-terminal truncated protein. We show that the novel c.34G>T (p.(E12*)) variant also reinitiated mRNA translation at the next AUG codon (c.121-123 (p.M41)), producing the same N-terminally truncated protein. The production of both of these truncated proteins was demonstrated to be at markedly reduced levels using in vitro cell assays. Using luciferase reporter assays, we demonstrate that transcriptional repression capacity of ARX was diminished by both the loss of the N-terminal corepressor octapeptide domain, as a consequence of truncation, and the marked reduction in mutant protein expression. Our study indicates that premature termination mutations very early in ARX lead to reinitiation of translation to produce N-terminally truncated protein at markedly reduced levels of expression. We conclude that even low levels of N-terminally truncated ARX is sufficient to improve the patient's phenotype compared with the severe phenotype of XLAG that includes malformations of the brain and genitalia normally seen in complete loss-of-function mutations in ARX.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26306640      PMCID: PMC4930085          DOI: 10.1038/ejhg.2015.176

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  49 in total

1.  A novel in-frame deletion in ARX is associated with lissencephaly with absent corpus callosum and hypoplastic genitalia.

Authors:  Shambhu S Bhat; R Curtis Rogers; Kenton R Holden; Anand K Srivastava
Journal:  Am J Med Genet A       Date:  2005-09-15       Impact factor: 2.802

2.  DMD exon 1 truncating point mutations: amelioration of phenotype by alternative translation initiation in exon 6.

Authors:  Olga L Gurvich; Baijayanta Maiti; Robert B Weiss; Gaurav Aggarwal; Michael T Howard; Kevin M Flanigan
Journal:  Hum Mutat       Date:  2009-04       Impact factor: 4.878

3.  Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsy.

Authors:  Petter Strømme; Marie E Mangelsdorf; Marie A Shaw; Karen M Lower; Suzanne M E Lewis; Helene Bruyere; Viggo Lütcherath; Agi K Gedeon; Robyn H Wallace; Ingrid E Scheffer; Gillian Turner; Michael Partington; Suzanna G M Frints; Jean-Pierre Fryns; Grant R Sutherland; John C Mulley; Jozef Gécz
Journal:  Nat Genet       Date:  2002-03-11       Impact factor: 38.330

4.  Selection of initiation sites by eucaryotic ribosomes: effect of inserting AUG triplets upstream from the coding sequence for preproinsulin.

Authors:  M Kozak
Journal:  Nucleic Acids Res       Date:  1984-05-11       Impact factor: 16.971

5.  Mutations in the nuclear localization sequence of the Aristaless related homeobox; sequestration of mutant ARX with IPO13 disrupts normal subcellular distribution of the transcription factor and retards cell division.

Authors:  Cheryl Shoubridge; May Huey Tan; Tod Fullston; Desiree Cloosterman; David Coman; George McGillivray; Grazia M Mancini; Tjitske Kleefstra; Jozef Gécz
Journal:  Pathogenetics       Date:  2010-01-05

6.  ARX mutations in X-linked lissencephaly with abnormal genitalia.

Authors:  G Uyanik; L Aigner; P Martin; C Gross; D Neumann; H Marschner-Schäfer; U Hehr; J Winkler
Journal:  Neurology       Date:  2003-07-22       Impact factor: 9.910

7.  Expansion of the first PolyA tract of ARX causes infantile spasms and status dystonicus.

Authors:  R Guerrini; F Moro; M Kato; A J Barkovich; T Shiihara; M A McShane; J Hurst; M Loi; J Tohyama; V Norci; K Hayasaka; U J Kang; S Das; W B Dobyns
Journal:  Neurology       Date:  2007-07-31       Impact factor: 9.910

8.  Aristaless-related homeobox gene, the gene responsible for West syndrome and related disorders, is a Groucho/transducin-like enhancer of split dependent transcriptional repressor.

Authors:  O McKenzie; I Ponte; M Mangelsdorf; M Finnis; G Colasante; C Shoubridge; S Stifani; J Gécz; V Broccoli
Journal:  Neuroscience       Date:  2007-02-27       Impact factor: 3.590

9.  Identification of Arx targets unveils new candidates for controlling cortical interneuron migration and differentiation.

Authors:  Gaëlle Friocourt; John G Parnavelas
Journal:  Front Cell Neurosci       Date:  2011-12-27       Impact factor: 5.505

10.  Cofactor-activated phosphorylation is required for inhibition of cortical neuron differentiation by Groucho/TLE1.

Authors:  Manuel Buscarlet; Robert Hermann; Rita Lo; Yeman Tang; Kerline Joachim; Stefano Stifani
Journal:  PLoS One       Date:  2009-12-01       Impact factor: 3.240

View more
  7 in total

1.  A purely quantitative form of partial recessive IFN-γR2 deficiency caused by mutations of the initiation or second codon.

Authors:  Carmen Oleaga-Quintas; Caroline Deswarte; Marcela Moncada-Vélez; Ayse Metin; Indumathi Krishna Rao; Saliha Kanık-Yüksek; Alejandro Nieto-Patlán; Antoine Guérin; Belgin Gülhan; Savita Murthy; Aslınur Özkaya-Parlakay; Laurent Abel; Rubén Martínez-Barricarte; Rebeca Pérez de Diego; Stéphanie Boisson-Dupuis; Xiao-Fei Kong; Jean-Laurent Casanova; Jacinta Bustamante
Journal:  Hum Mol Genet       Date:  2018-11-15       Impact factor: 6.150

2.  Nonsense mutation-dependent reinitiation of translation in mammalian cells.

Authors:  Sarit Cohen; Lior Kramarski; Shahar Levi; Noa Deshe; Oshrit Ben David; Eyal Arbely
Journal:  Nucleic Acids Res       Date:  2019-07-09       Impact factor: 16.971

3.  Nonsense pathogenic variants in exon 1 of PHOX2B lead to translational reinitiation in congenital central hypoventilation syndrome.

Authors:  Jacob T Cain; Dae I Kim; Megan Quast; Winnie G Shivega; Ryan J Patrick; Chuanpit Moser; Suzanne Reuter; Myrza Perez; Angela Myers; Jill M Weimer; Kyle J Roux; Megan Landsverk
Journal:  Am J Med Genet A       Date:  2017-03-29       Impact factor: 2.802

Review 4.  Modeling epileptic spasms during infancy: Are we heading for the treatment yet?

Authors:  Libor Velíšek; Jana Velíšková
Journal:  Pharmacol Ther       Date:  2020-05-15       Impact factor: 12.310

5.  Regulating transcriptional activity by phosphorylation: A new mechanism for the ARX homeodomain transcription factor.

Authors:  Tessa Mattiske; May H Tan; Oliver Dearsley; Desiree Cloosterman; Charles S Hii; Jozef Gécz; Cheryl Shoubridge
Journal:  PLoS One       Date:  2018-11-12       Impact factor: 3.240

6.  A de novo frameshift pathogenic variant in TBR1 identified in autism without intellectual disability.

Authors:  Laurie-Anne Sapey-Triomphe; Julie Reversat; Gaëtan Lesca; Nicolas Chatron; Marina Bussa; Sylvie Mazoyer; Christina Schmitz; Sandrine Sonié; Patrick Edery
Journal:  Hum Genomics       Date:  2020-09-18       Impact factor: 4.639

7.  Heterozygous nonsense ARX mutation in a family highlights the complexity of clinical and molecular diagnosis in case of chromosomal and single gene disorder co-inheritance.

Authors:  Alice Traversa; Enrica Marchionni; Agnese Giovannetti; Maria L Genovesi; Noemi Panzironi; Katia Margiotti; Giulia Napoli; Francesca Piceci Sparascio; Alessandro De Luca; Francesco Petrizzelli; Massimo Carella; Francesco Cardona; Silvia Bernardo; Lucia Manganaro; Tommaso Mazza; Antonio Pizzuti; Viviana Caputo
Journal:  Mol Genet Genomic Med       Date:  2020-06-10       Impact factor: 2.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.